Abbott Laboratories Other Operating Income or Expenses 2010-2024 | ABT

Abbott Laboratories annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Abbott Laboratories other operating income or expenses for the quarter ending September 30, 2024 were $M, a NAN% increase year-over-year.
  • Abbott Laboratories other operating income or expenses for the twelve months ending September 30, 2024 were $0M, a NAN% increase year-over-year.
  • Abbott Laboratories annual other operating income or expenses for 2023 were $0B, a NAN% decline from 2022.
  • Abbott Laboratories annual other operating income or expenses for 2022 were $0B, a NAN% decline from 2021.
  • Abbott Laboratories annual other operating income or expenses for 2021 were $0B, a NAN% decline from 2020.
Abbott Laboratories Annual Other Operating Income or Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Abbott Laboratories Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $202.584B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $144.427B 32.55
Boston Scientific (BSX) United States $130.404B 37.49
Medtronic (MDT) Ireland $113.203B 16.84
EssilorLuxottica (ESLOY) France $112.107B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.279B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
GE HealthCare Technologies (GEHC) United States $39.012B 20.24
ResMed (RMD) United States $36.507B 30.00
Terumo (TRUMY) Japan $30.649B 43.28
Koninklijke Philips (PHG) Netherlands $24.871B 19.04
Zimmer Biomet Holdings (ZBH) United States $21.791B 13.87
Insulet (PODD) United States $19.339B 77.01
Baxter (BAX) United States $17.458B 11.37
Smith & Nephew SNATS (SNN) United Kingdom $10.816B 0.00
Bio-Rad Laboratories (BIO) United States $10.245B 34.82
BellRing Brands (BRBR) United States $9.218B 38.97
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $5.846B 13.58
TG Therapeutics (TGTX) United States $4.785B 0.00
Haemonetics (HAE) United States $4.590B 22.40
ICU Medical (ICUI) United States $4.354B 41.56
Prestige Consumer Healthcare (PBH) United States $4.039B 20.09
Perrigo (PRGO) Ireland $3.645B 10.73
Envista Holdings (NVST) United States $3.571B 26.60
Neogen (NEOG) United States $3.554B 41.00
Agios Pharmaceuticals (AGIO) United States $3.448B 0.00
GN Store Nord (GNNDY) Denmark $3.068B 19.67
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.891B 18.61
LeMaitre Vascular (LMAT) United States $2.372B 57.65
Warby Parker (WRBY) United States $2.084B 0.00
AtriCure (ATRC) United States $1.862B 0.00
Green Thumb Industries (GTBIF) United States $1.651B 28.90
InMode (INMD) Israel $1.638B 9.85
Maravai LifeSciences Holdings (MRVI) United States $1.458B 0.00
AdaptHealth (AHCO) United States $1.405B 10.05
BioLife Solutions (BLFS) United States $1.227B 0.00
Curaleaf Holdings (CURLF) Canada $1.079B 0.00
Phibro Animal Health (PAHC) United States $1.035B 18.25
Owens & Minor (OMI) United States $1.031B 8.05
CeriBell (CBLL) United States $0.983B 0.00
National Vision Holdings (EYE) United States $0.931B 31.10
Capricor Therapeutics (CAPR) United States $0.887B 0.00
Evolus (EOLS) United States $0.831B 0.00
VAREX IMAGING (VREX) United States $0.598B 18.04
Quanterix (QTRX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Verano Holdings (VRNOF) United States $0.546B 0.00
Cresco Labs (CRLBF) United States $0.508B 0.00
Valneva SE (VALN) France $0.417B 0.00
ZimVie (ZIMV) United States $0.394B 33.19
Canopy Growth (CGC) Canada $0.379B 0.00
Cerus (CERS) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.370B 35.22
OraSure Technologies (OSUR) United States $0.316B 21.20
Biote (BTMD) United States $0.312B 14.38
Sanara MedTech (SMTI) United States $0.306B 0.00
Zynex (ZYXI) United States $0.296B 62.00
MacroGenics (MGNX) United States $0.276B 0.00
Aurora Cannabis (ACB) Canada $0.262B 0.00
Jin Medical (ZJYL) China $0.250B 0.00
Omeros (OMER) United States $0.249B 0.00
Utah Medical Products (UTMD) United States $0.238B 16.05
High Tide (HITI) Canada $0.213B 88.33
TerrAscend (TSNDF) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.180B 216.00
Organigram Holdings (OGI) Canada $0.169B 0.00
FitLife Brands (FTLF) United States $0.155B 20.99
Rockwell Medical (RMTI) United States $0.144B 0.00
Zevia PBC (ZVIA) United States $0.140B 0.00
TriSalus Life Sciences (TLSI) United States $0.137B 0.00
Quipt Home Medical (QIPT) United States $0.117B 0.00
Veru (VERU) United States $0.106B 0.00
Fonar (FONR) United States $0.094B 9.76
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.20
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Ayr Wellness (AYRWF) United States $0.081B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.69
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.066B 0.00
Safety Shot (SHOT) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.055B 0.00
Jushi Holdings (JUSHF) United States $0.053B 0.00
Exagen (XGN) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Allurion Technologies (ALUR) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.60
SNDL (SNDL) Canada $0.000B 0.00